Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04637321

The Incidence and Risk Factors for Clostridioides Difficle Infection in Solid Organ Transplant Recipients

Infection in Solid Organ Transplant Recipients Clinical Trial

Official title:
Everyone Poops: An Evaluation of the Incidence and Risk Factors for Clostridioides Difficle Infection in Solid Organ Transplant Recipients

Clinical Trial Summary

2.1. Study Objectives - Primary Objective(s) - Identify the incidence and risk of CDI within one year after kidney, liver, and/or pancreas transplant - Secondary Objective(s) - Identify the risk factors for recurrent CDI post-transplant in patients who were diagnosed with a CDI within one year prior to Solid Organ Transplant - Evaluate the impact of CDI on graft survival following Solid Organ Transplant

Clinical Trial Description

- Single center, retrospective cohort chart review study design - Data will be collected on all liver, kidney, pancreas and combined transplant recipients who received their graft(s) from April 1, 2015 to July 31, 2018 - Will analyze outcomes from April 1, 2014 to July 31, 2019 - Patient list will be generated in Epic and Meditech - All data will be obtained from Epic and Meditech - All data will be collected retrospectively after the patient is discharged from the hospital ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04637321
Study type Observational
Source Methodist Health System
Contact
Status Completed
Phase
Start date November 4, 2019
Completion date August 7, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT02260596 - Respiratory Viral Infections in Pediatric Transplantation N/A
Completed NCT01761435 - Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination Phase 3
Completed NCT02382211 - T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays
Terminated NCT01761201 - "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients". Phase 3
Recruiting NCT05626530 - Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients Phase 4
Active, not recruiting NCT01527591 - Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT) N/A
Recruiting NCT02503982 - Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients Phase 4
Completed NCT01446445 - Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients. Phase 4
Completed NCT01833416 - Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients N/A
Completed NCT01558037 - Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients N/A